Predictors of inferior clinical outcome in patients with standard risk multiple myeloma

ConclusionOur analysis suggests that concurrent AL and soft‐tissue plasmacytoma were associated with shorter PFS and OS, respectively. Heterogeneity in clinical outcome of SR MM merits better tools for prognostication, such as gene expression profiling and minimal residual disease assessment to identify high‐risk patients.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - June 30, 2016 Category: Hematology Authors: Talha Badar, Samer Srour, Qaiser Bashir, Nina Shah, Gheath Al ‐Atrash, Chitra Hosing, Uday Popat, Yago Nieto, Robert Z. Orlowski, Richard Champlin, Muzaffar H. Qazilbash Tags: Original Article Source Type: research